Inhibition of microglial inflammation by the MLK inhibitor CEP-1347
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
CEP-1347 is a potent inhibitor of the mixed lineage kinases (MLKs), a distinct family of mitogen-activated protein kinase kinase kinases (MAPKKK). It blocks the activation of the c-Jun/JNK apoptotic pathway in neurons exposed to various stressors and attenuates neurodegeneration in animal models of Parkinson's disease (PD). Microglial activation may involve kinase pathways controlled by MLKs and might contribute to the pathology of neurodegenerative diseases. Therefore, the possibility that CEP-1347 modulates the microglial inflammatory response [tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemotactic protein-1 (MCP-1)] was explored. Indeed, the MLK inhibitor CEP-1347 reduced cytokine production in primary cultures of human and murine microglia, and in monocyte/macrophage-derived cell lines, stimulated with various endotoxins or the plaque forming peptide Aβ1 40. Moreover, CEP-1347 inhibited brain TNF production induced by intracerebroventricular injection of lipopolysaccharide in mice. As expected from a MLK inhibitor, CEP-1347 acted upstream of p38 and c-Jun activation in microglia by dampening the activity of both pathways. These data imply MLKs as important, yet unrecognized, modulators of microglial inflammation, and demonstrate a novel anti-inflammatory potential of CEP-1347.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
LUND, Søren, Peter PORZGEN, Anna-Louise MORTENSEN, Henrik HASSELDAM, Donna BOZYCZKO-COYNE, Siegfried MORATH, Thomas HARTUNG, Marina BIANCHI, Pietro GHEZZI, Malika BSIBSI, Sipke DIJKSTRA, Marcel LEIST, 2005. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347. In: Journal of Neurochemistry. 2005, 92(6), pp. 1439-1451. ISSN 0022-3042. eISSN 1471-4159. Available under: doi: 10.1111/j.1471-4159.2005.03014.xBibTex
@article{Lund2005Inhib-8000, year={2005}, doi={10.1111/j.1471-4159.2005.03014.x}, title={Inhibition of microglial inflammation by the MLK inhibitor CEP-1347}, number={6}, volume={92}, issn={0022-3042}, journal={Journal of Neurochemistry}, pages={1439--1451}, author={Lund, Søren and Porzgen, Peter and Mortensen, Anna-Louise and Hasseldam, Henrik and Bozyczko-Coyne, Donna and Morath, Siegfried and Hartung, Thomas and Bianchi, Marina and Ghezzi, Pietro and Bsibsi, Malika and Dijkstra, Sipke and Leist, Marcel} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/8000"> <dc:creator>Bozyczko-Coyne, Donna</dc:creator> <dc:creator>Hasseldam, Henrik</dc:creator> <dc:contributor>Bozyczko-Coyne, Donna</dc:contributor> <dc:creator>Ghezzi, Pietro</dc:creator> <dc:contributor>Hartung, Thomas</dc:contributor> <dc:contributor>Leist, Marcel</dc:contributor> <dc:contributor>Ghezzi, Pietro</dc:contributor> <dc:contributor>Lund, Søren</dc:contributor> <dc:contributor>Morath, Siegfried</dc:contributor> <dc:contributor>Bsibsi, Malika</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Mortensen, Anna-Louise</dc:contributor> <dcterms:bibliographicCitation>First publ. in: Journal of Neurochemistry 92 (2005), 6, pp. 1439-1451</dcterms:bibliographicCitation> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8000/1/Inhibition_of_microglial_inflammation_by_the_MLK_inhibitor.pdf"/> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/8000"/> <dc:contributor>Porzgen, Peter</dc:contributor> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8000/1/Inhibition_of_microglial_inflammation_by_the_MLK_inhibitor.pdf"/> <dc:creator>Hartung, Thomas</dc:creator> <dcterms:abstract xml:lang="eng">CEP-1347 is a potent inhibitor of the mixed lineage kinases (MLKs), a distinct family of mitogen-activated protein kinase kinase kinases (MAPKKK). It blocks the activation of the c-Jun/JNK apoptotic pathway in neurons exposed to various stressors and attenuates neurodegeneration in animal models of Parkinson's disease (PD). Microglial activation may involve kinase pathways controlled by MLKs and might contribute to the pathology of neurodegenerative diseases. Therefore, the possibility that CEP-1347 modulates the microglial inflammatory response [tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemotactic protein-1 (MCP-1)] was explored. Indeed, the MLK inhibitor CEP-1347 reduced cytokine production in primary cultures of human and murine microglia, and in monocyte/macrophage-derived cell lines, stimulated with various endotoxins or the plaque forming peptide Aβ1 40. Moreover, CEP-1347 inhibited brain TNF production induced by intracerebroventricular injection of lipopolysaccharide in mice. As expected from a MLK inhibitor, CEP-1347 acted upstream of p38 and c-Jun activation in microglia by dampening the activity of both pathways. These data imply MLKs as important, yet unrecognized, modulators of microglial inflammation, and demonstrate a novel anti-inflammatory potential of CEP-1347.</dcterms:abstract> <dc:contributor>Hasseldam, Henrik</dc:contributor> <dc:contributor>Bianchi, Marina</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:39:11Z</dc:date> <dc:creator>Porzgen, Peter</dc:creator> <dc:format>application/pdf</dc:format> <dcterms:issued>2005</dcterms:issued> <dc:language>eng</dc:language> <dc:creator>Mortensen, Anna-Louise</dc:creator> <dc:creator>Dijkstra, Sipke</dc:creator> <dc:creator>Bsibsi, Malika</dc:creator> <dc:creator>Morath, Siegfried</dc:creator> <dc:rights>terms-of-use</dc:rights> <dc:creator>Bianchi, Marina</dc:creator> <dc:contributor>Dijkstra, Sipke</dc:contributor> <dc:creator>Leist, Marcel</dc:creator> <dc:creator>Lund, Søren</dc:creator> <dcterms:title>Inhibition of microglial inflammation by the MLK inhibitor CEP-1347</dcterms:title> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:39:11Z</dcterms:available> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> </rdf:Description> </rdf:RDF>